Applied Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.321; its P/E ratio is -3.34; Applied Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ -667.00K	-	-	$ 10.66M	-
Gross Profit	$ -667.00K	-	-	$ 10.66M	-
EBIT	$ -37.68M	$ -42.37M	$ -29.58M	$ -10.14M	$ -14.70M
EBITDA	$ -37.28M	$ -41.86M	$ -28.89M	$ -9.26M	$ -13.80M
Net Income Common Stockholders	$ -37.68M	$ -42.37M	$ -59.15M	$ -20.27M	$ -28.86M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 49.90M	$ 37.50M	$ 35.60M	$ 22.92M	$ 30.58M
Total Assets	$ 54.83M	$ 45.20M	$ 43.63M	$ 30.00M	$ 38.36M
Total Debt	$ 467.00K	$ 535.00K	$ 656.00K	$ 774.00K	$ 891.00K
Net Debt	$ -49.43M	$ -36.97M	$ -34.94M	$ -22.14M	$ -29.69M
Total Liabilities	$ 71.98M	$ 56.24M	$ 47.98M	$ 34.08M	$ 34.30M
Stockholders Equity	$ -17.15M	$ -11.04M	$ -4.30M	$ -4.11M	$ 4.06M
Cash Flow	-
Free Cash Flow	$ -17.00M	$ -14.74M	$ -16.48M	$ -6.95M	$ -15.89M
Operating Cash Flow	$ -17.00M	$ -14.74M	$ -16.48M	$ -6.95M	$ -15.89M
Investing Cash Flow	-	-	-	$ 13.87M	$ -6.91M
Financing Cash Flow	$ 29.45M	$ 16.57M	$ 29.15M	$ -622.00K	$ -933.00K

Currency in USD

Applied Therapeutics Earnings and Revenue History

Income Statement >

Applied Therapeutics Debt to Assets

Balance Sheet >

Applied Therapeutics Cash Flow

Cash Flow >

Applied Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing